{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:59:36Z","timestamp":1790261976949,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.ejpb.2020.08.022","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T20:19:16Z","timestamp":1598732356000},"page":"190-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model"],"prefix":"10.1016","volume":"155","author":[{"given":"Pui S.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.W.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon S.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.08.022_b0005","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1039\/C6TB02158A","article-title":"Modified PLGA\u2013PEG\u2013PLGA thermosensitive hydrogels with suitable thermosensitivity and properties for use in a drug delivery system","volume":"5","author":"Wang","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2020.08.022_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/jop.2009.0059","article-title":"Sustained subconjunctival protein delivery using a thermosetting gel delivery system","volume":"26","author":"Rieke","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2020.08.022_b0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2006.132","article-title":"Controlled delivery of ganciclovir to the retina with drug-loaded poly (d, L-lactide-coglycolide)(PLGA) microspheres dispersed in PLGA-PEG-PLGA gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis","volume":"23","author":"Duvvuri","year":"2007","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejpb.2020.08.022_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.actbio.2015.05.005","article-title":"Sustained intravitreal delivery of dexamethasone using an injectable and biodegradable thermogel","volume":"23","author":"Zhang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2020.08.022_b0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin\u00ae to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.022_b0030","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jddst.2018.12.032","article-title":"Biocompatibility and safety of insulin-loaded chitosan nanoparticles\/ PLGA-PEG-PLGA hydrogel (ICNPH) delivered by subconjunctival injection in rats","volume":"49","author":"Rong","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2020.08.022_b0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/10717544.2019.1609623","article-title":"Co-delivery of metformin and levofloxacin hydrochloride using biodegradable thermosensitive hydrogel for the treatment of corneal neovascularization","volume":"26","author":"Liu","year":"2019","journal-title":"Drug Delivery"},{"key":"10.1016\/j.ejpb.2020.08.022_b0040","first-page":"5356371","article-title":"Ocular Biocompatibility of Poly-N-Isopropylacrylamide (pNIPAM)","author":"Lima","year":"2016","journal-title":"J Ophthalmol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0045","doi-asserted-by":"crossref","first-page":"e67495","DOI":"10.1371\/journal.pone.0067495","article-title":"Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(epsilon-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127","volume":"8","author":"Hwang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2020.08.022_b0050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1208\/s12248-019-0326-x","article-title":"Biodegradable thermosensitive PLGA-PEG-PLGA polymer for non-irritating and sustained ophthalmic drug delivery","volume":"21","author":"Chan","year":"2019","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.08.022_b0055","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1023\/A:1011074915438","article-title":"Controlled release of insulin from injectable biodegradable triblock copolymer","volume":"18","author":"Kim","year":"2001","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jconrel.2015.12.015","article-title":"PEG-B-PLA micelles and PLGA-B-PEG-B-PLGA sol\u2013gels for drug delivery","volume":"240","author":"Cho","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.022_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(01)00276-0","article-title":"Biodegradable block copolymers for delivery of proteins and water-insoluble drugs","volume":"72","author":"Zentner","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.022_b0070","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1\u03b2-induced corneal neovascularization: role of nuclear factor-\u03baB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0075","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2014.06.006","article-title":"Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model","volume":"125","author":"Mirabelli","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/IJG.0b013e31814b990d","article-title":"Barriers to glaucoma drug delivery","volume":"17","author":"Ghate","year":"2008","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ejpb.2020.08.022_b0085","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.08.022_b0090","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/17425247.3.2.261","article-title":"Drug delivery from ocular implants","volume":"3","author":"Yasukawa","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2020.08.022_b0095","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ICU.0b013e328338679a","article-title":"Complications of intravitreal injections","volume":"21","author":"Sampat","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0105","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0161-6420(00)00344-4","article-title":"Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose","volume":"107","author":"Weijtens","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2020.08.022_b0110","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archopht.120.8.1069","article-title":"Transscleral diffusion of carboplatin: an in vitro and in vivo study","volume":"120","author":"Simpson","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000266253","article-title":"Intraocular penetration kinetics of prednisolone after subconjunctival injection in rabbits","volume":"20","author":"Tsuji","year":"1988","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0120","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1021\/bm900145g","article-title":"Mixing a sol and a precipitate of block copolymers with different block ratios leads to an injectable hydrogel","volume":"10","author":"Yu","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2020.08.022_b0125","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1021\/bm101572j","article-title":"Influence of LA and GA sequence in the PLGA block on the properties of thermogelling PLGA-PEG-PLGA block copolymers","volume":"12","author":"Yu","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2020.08.022_b0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.80.1.29","article-title":"Corneal temperature in patients with dry eye evaluated by infrared radiation thermometry","volume":"80","author":"Fujishima","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ICL.0000141921.80061.17","article-title":"Ocular surface temperature: a review","volume":"31","author":"Purslow","year":"2005","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejpb.2020.08.022_b0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1023\/B:PHAM.0000026435.27086.94","article-title":"Control of blood glucose by novel GLP-1 delivery using biodegradable triblock copolymer of PLGA-PEG-PLGA in type 2 diabetic rats","volume":"21","author":"Choi","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijpharm.2005.01.017","article-title":"Injectable biodegradable temperature-responsive PLGA\u2013PEG\u2013PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels","volume":"294","author":"Qiao","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.022_b0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","article-title":"DDSolver: An add-in program for modeling and comparison of drug dissolution profiles","volume":"12","author":"Zhang","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.08.022_b0155","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1023\/A:1026164123938","article-title":"Low potential ocular irritation of arginine-based gemini surfactants and their mixtures with nonionic and zwitterionic surfactants","volume":"20","author":"Mitjans","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.toxlet.2006.01.005","article-title":"Evaluation of eye and skin irritation of arginine-derivative surfactants using different in vitro endpoints as alternatives to the in vivo assays","volume":"164","author":"Martinez","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejpb.2020.08.022_b0165","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1248\/bpb.18.540","article-title":"Hemoglobin denaturation caused by surfactants","volume":"18","author":"Hayashi","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2020.08.022_b0170","first-page":"71","article-title":"Hemolytic action of anionic surfactants of the diacyl lysine type","volume":"118","author":"Vives","year":"1997","journal-title":"Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02713688508999984","article-title":"Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea","volume":"4","author":"Mahoney","year":"1985","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2020.08.022_b0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0278-6915(93)90182-X","article-title":"Justification of the enucleated eye test with eyes of slaughterhouse animals as an alternative to the draize eye irritation test with rabbits","volume":"31","author":"Prinsen","year":"1993","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/0929867311302010009","article-title":"Thermosensitive polymeric hydrogels as drug delivery systems","volume":"20","author":"Gong","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejpb.2020.08.022_b0190","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1016\/j.biomaterials.2011.08.014","article-title":"Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy","volume":"32","author":"Hua","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.08.022_b0195","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1021\/acs.molpharmaceut.5b00085","article-title":"Oleanolic acid loaded PEGylated PLA and PLGA nanoparticles with enhanced cytotoxic activity against cancer cells","volume":"12","author":"Man","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.022_b0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.022_b0205","doi-asserted-by":"crossref","first-page":"10032","DOI":"10.1021\/jp027339n","article-title":"Phase transition of the PLGA-G-PEG copolymer aqueous solutions","volume":"107","author":"Jeong","year":"2003","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejpb.2020.08.022_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.07.026","article-title":"Injectable block copolymer hydrogels for sustained release of a PEGylated drug","volume":"348","author":"Yu","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.08.022_b0215","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/bm5017805","article-title":"Self-Assembling Polymer micelle\/clay nanodisk\/doxorubicin hybrid injectable gels for safe and efficient focal treatment of cancer","volume":"16","author":"Nagahama","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2020.08.022_b0220","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1039\/c3nr02937a","article-title":"Janus nanogels of PEGylated taxol and PLGA\u2013PEG\u2013PLGA copolymer for cancer therapy","volume":"5","author":"Wei","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2020.08.022_b0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.08.022_b0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0168-3659(00)00349-7","article-title":"Mechanistic modeling of drug release from chitosan coated tablets","volume":"70","author":"Koizumi","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.08.022_b0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2125.1999.00930.x","article-title":"Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans","volume":"47","author":"Mayer","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0240","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fct.2006.10.024","article-title":"Comparative studies on the ocular and dermal irritation potential of surfactants","volume":"45","author":"Mehling","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejpb.2020.08.022_b0245","first-page":"498","article-title":"Standardization of an in vitro red blood cell test for evaluating the acute cytotoxic potential of tensides","volume":"40","author":"Pape","year":"1990","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejpb.2020.08.022_b0250","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0887-2333(98)00085-X","article-title":"COLIPA validation project on in vitro eye irritation tests for cosmetic ingredients and finished products (Phase I): The red blood cell test for the estimation of acute eye irritation potentials. Present status","volume":"13","author":"Pape","year":"1999","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejpb.2020.08.022_b0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0887-2333(98)00066-6","article-title":"Interlaboratory validation of the in vitro eye irritation tests for cosmetic ingredients. (3) Evaluation of the haemolysis test","volume":"13","author":"Okamoto","year":"1999","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejpb.2020.08.022_b0260","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jps.21088","article-title":"Alternative methods for eye and skin irritation tests: an overview","volume":"97","author":"Vinardell","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.08.022_b0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916939708996275","article-title":"High circulating IL-6 level in graves' ophthalmopathy","volume":"25","author":"Moln\u00e1r","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejpb.2020.08.022_b0270","doi-asserted-by":"crossref","first-page":"92196","DOI":"10.1155\/2007\/92196","article-title":"Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children","volume":"2007","author":"Zorena","year":"2007","journal-title":"Mediators Inflamm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120302666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:39:42Z","timestamp":1760546382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120302666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":54,"alternative-id":["S0939641120302666"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.022","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}